Mark Dallas is Associate Professor in Cellular Neuroscience at the University of Reading. In this blog for World Alzheimer’s Day he gives an overview of dementia research in 2023. 2023…Read More >
Alzheimer’s disease is often thought of as a condition that only affects the elderly. But around 3.9 million people worldwide aged 30-64 live with young-onset Alzheimer’s disease – a form of dementia…Read More >
For World Alzheimer’s Day on 21 September, Nagihan Ozsoy, a doctoral researcher working with Dr Mark Dallas in the Reading School of Pharmacy, explains the importance of her new research…Read More >
A scientist-cum-detective has presented evidence that images used to support the case for amyloid protein being the main protagonist in Alzheimer’s disease appear to have been fabricated.
Dr Mark Dallas from Pharmacy explains how he has enlisted the skills of an artist to bring the wonders of neuroscience to schoolchildren.
About two in ten people over the age of 65 have mild cognitive impairment – a noticeable change in their memory, problem-solving abilities or attention. This is caused, in part,…Read More >
Although there’s still no cure, researchers are continuing to develop a better understanding of what increases a person’s risk of developing Alzheimer’s disease. Here, Dr Mark Dallas outlines the ten…Read More >
From finding brain changes decades before dementia strikes to exploring the protective effects of speaking another language, Reading researchers are targeting the disease on several fronts. For World Alzheimer’s Day,…Read More >
It’s Dementia Action Week. Reading researchers are tackling the problem of dementia on all fronts, from investigating its causes to how we can improve care and quality of life for…Read More >
50 million people around the world are living with dementia and that figure is set to reach 152 million by 2050. Ahead of tonight’s public lecture, neuroscientist Dr Mark Dallas…Read More >